Clinical Trial Update: GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a GlaxoSmithKline drug given as a single dose to healthy volunteers and its effect on resting motor threshold; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• GSK Drug

Snippet

Sponsor: Biogen | Conditions: Bipolar Disorder | Phase 1 | Status: COMPLETED